Abstract Details
|
Sara H. Duffus
(Wake Forest School of Medicine)
PRESENTER |
No disclosure on file |
| Laura Bishop, DO (eviCore Healthcare) | No disclosure on file |
| No disclosure on file | |
| Robert A. Bermel, MD, FAAN (Cleveland Clinic) | Dr. Bermel has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi/Genzyme. Dr. Bermel has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech/Roche. Dr. Bermel has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Bermel has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for TG Therapeutics. The institution of Dr. Bermel has received research support from Biogen. The institution of Dr. Bermel has received research support from Roche. The institution of Dr. Bermel has received research support from Novartis. Dr. Bermel has received intellectual property interests from a discovery or technology relating to health care. |
| Ihtsham Haq, MD, FAAN (University of Miami Miller School of Medicine) | The institution of Dr. Haq has received research support from NINDS. The institution of Dr. Haq has received research support from the Parkinson's Foundation. |